New Ebola AESI List Added
May 29, 2026
SPEAC has created an Ebola Adverse Events of Special Interest (AESI) List, to support the vaccine response to the 2026 Bundibugyo virus disease epidemic in
SPEAC has created an Ebola Adverse Events of Special Interest (AESI) List, to support the vaccine response to the 2026 Bundibugyo virus disease epidemic in
SPEAC has launched a new Educational Resource Library to support the effective use of its vaccine safety tools and resources. As the SPEAC portfolio
SPEAC has launched a new set of dashboards on the CEPI Safety Vaccine Intelligence platform (CVSI), continuing efforts to translate established vaccine safety standards into
Clinical trials are conducted within established scientific and ethical frameworks designed to support consistent and well-governed research. Data and Safety Monitoring Boards (DSMBs) are
The World Vaccine Congress brings together global stakeholders across vaccine development, safety, and policy. At this year’s meeting, beginning March 30 in Washington, D.C., SPEAC
Guillain-Barré Syndrome, or GBS, is a rare but serious neurological disorder that can cause sudden muscle weakness or flaccid paralysis. Although uncommon, the condition
The Safety Platform for Emergency vACcines (SPEAC) is a project funded by the Coalition for Epidemic Preparedness Innovations (CEPI). SPEAC is located at Brighton Collaboration, a program of the Task Force for Global Health.
© SPEAC 2023. All rights reserved.